About Astute Medical
Astute Medical is a company based in San Diego (United States) founded in 2007 was acquired by BioMerieux in April 2018. Astute Medical has raised $206.5 million across 11 funding rounds from investors including BioMerieux, Turmeric Acquisition Corp and Kaiser Permanente Ventures. The company has 51 employees as of December 31, 2017. Astute Medical offers products and services including BIOFIRE, VIDAS, and VITEK. Astute Medical operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
- Headquarter San Diego, United States
- Employees 51 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Astute Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$206.5 M (USD)
in 11 rounds
-
Latest Funding Round
$43.03 M (USD), Series D
Dec 16, 2016
-
Investors
BioMerieux
& 6 more
-
Employee Count
51
as on Dec 31, 2017
-
Acquired by
BioMerieux
(Apr 04, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Astute Medical
Astute Medical offers a comprehensive portfolio of products and services, including BIOFIRE, VIDAS, and VITEK.
Rapid molecular testing for infectious diseases detection.
Automated immunoassays for clinical diagnostics.
Identification and susceptibility testing for bacteria.
Funding Insights of Astute Medical
Astute Medical has successfully raised a total of $206.5M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $43.03 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Astute Medical
Astute Medical has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include BioMerieux, Turmeric Acquisition Corp and Kaiser Permanente Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and Life Sciences focused corporate VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked |
Investor details for Astute Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Astute Medical
Investment portfolio details for Astute Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Astute Medical
Detailed financials for Astute Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Astute Medical Comparisons
Peer comparison for Astute Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Astute Medical
Astute Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Seer, Alector and Scailyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| Locked | Locked | Locked |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Single-cell data is analyzed via AI for biomarker discovery.
|
|
| Locked | Locked | Locked |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
Detailed competitors of Astute Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Astute Medical
Complete news archive for Astute Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Astute Medical
Astute Medical was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Astute Medical is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Astute Medical is a funded company, having raised a total of $206.5M across 11 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Astute Medical is 51.
Astute Medical provides solutions for diagnosis of high-risk medical conditions and diseases through the identification and validation of biomarkers using a systems biology approach, which integrates information from pathway analysis, proteomics and genomics. The Companys current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Its first product, NephroCheck, received 510(k)-clearance through the FDAs de novo classification process in Sept14. It can be used to assess risk for acute kidney injury (AKI).
Astute Medical's top competitors include Alector, Maze Therapeutics and Metabolon.
Astute Medical offers BIOFIRE, VIDAS, and VITEK.
Astute Medical has 7 investors. Key investors include BioMerieux, Turmeric Acquisition Corp, Kaiser Permanente Ventures, De Novo Ventures, and Delphi Ventures.